Weight gain in women diagnosed with breast cancer.
暂无分享,去创建一个
E. Winer | B. Rimer | W. Demark-Wahnefried | B K Rimer | E P Winer | W Demark-Wahnefried | Eric P. Winer | E. Winer | W. Wahnefried
[1] R. Senie,et al. Obesity at Diagnosis of Breast Carcinoma Influences Duration of Disease-free Survival , 1992, Annals of Internal Medicine.
[2] I. Feurer,et al. Energy Expenditure in Malnourished Cancer Patients , 1983, Annals of surgery.
[3] E. Winer,et al. Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy. , 1997, The American journal of clinical nutrition.
[4] B. Meyerowitz,et al. Adjuvant chemotherapy for breast carcinoma: Psychosocial implications , 1979, Cancer.
[5] D. Schaid,et al. Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis , 1991, Cancer.
[6] D. Ota,et al. Obesity, non‐protein‐bound estradiol levels, and distribution of estradiol in the sera of breast cancer patients , 1986, Cancer.
[7] A. Hart,et al. Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk. , 1985, British Journal of Cancer.
[8] M. K. Knobf,et al. Weight gain in women with breast cancer receiving adjuvant chemotherapy. , 1983, Oncology nursing forum.
[9] G. Schneider,et al. Obesity, androgens, estrogens, and cancer risk. , 1982, Cancer research.
[10] L. H. Maurer,et al. Psychosocial aspects of neoplastic disease: I. Functional status of breast cancer patients during different treatment regimens. , 1980, The American journal of psychiatry.
[11] S. Gundersen,et al. Cyclical Use of Tamoxifen and High-Dose Medroxyprogesterone Acetate in Advanced Breast Cancer , 1987 .
[12] A. Kristal,et al. Weight loss in women participating in a randomized trial of low-fat diets. , 1991, The American journal of clinical nutrition.
[13] C. Redmond,et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. , 1989, The New England journal of medicine.
[14] Morgan Lr. Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients. , 1985 .
[15] J. Crave,et al. Pathophysiology of sex hormone binding globulin (SHBG): Relation to insulin , 1991, The Journal of Steroid Biochemistry and Molecular Biology.
[16] H. Parnes,et al. Appetite stimulation and weight gain with megestrol acetate. , 1990, Seminars in oncology.
[17] Dixon Jk,et al. Breast cancer and weight gain: an unexpected finding. , 1978 .
[18] P. Tartter,et al. Cholesterol and obesity as prognostic factors in breast cancer , 1981, Cancer.
[19] E. Winer,et al. Why women gain weight with adjuvant chemotherapy for breast cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] T. Brewin. CAN A TUMOUR CAUSE THE SAME APPETITE PERVERSION OR TASTE CHANGE AS A PREGNANCY? , 1980, The Lancet.
[21] T M Therneau,et al. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] P. Newberne,et al. Dietary lipids and immune function. , 1992, The Journal of nutrition.
[23] R. Prentice,et al. Results of a randomized feasibility study of a low-fat diet. , 1990, Archives of internal medicine.
[24] R. Elashoff,et al. Unpublished Data Summaries and the design and conduct of clinical trials. The Nutrition Adjuvant Study experience and commentary. , 1989, Controlled clinical trials.
[25] P. Taylor,et al. Association of change in body mass with breast cancer. , 1990, Cancer research.
[26] S. Hilsenbeck,et al. Clinical trial of high‐dose oral medroxyprogesterone acetate in the treatment of metastatic breast cancer and review of the literature , 1988, Cancer.
[27] L. Holm,et al. Dietary intervention in breast cancer patients: effects on dietary habits and nutrient intake. , 1990, European journal of clinical nutrition.
[28] M. Szklo,et al. Estrogen receptors and breast cancer. , 1986, Epidemiologic reviews.
[29] D. Lees,et al. Resting Energy Expenditure in Controls and Cancer Patients with Localized and Diffuse Disease , 1984, Annals of surgery.
[30] P. Sorlie,et al. Mortality Effects of Community Socioeconomic Status , 1997, Epidemiology.
[31] Glatt Mm,et al. Letter: Scientific medicine. , 1974 .
[32] D. Albanes,et al. Validation and Comparison of Eight Physical Activity Questionnaires , 1990, Epidemiology.
[33] J. Abrams,et al. Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] A. Tannenbaum. Relationship of body weight to cancer incidence. , 1940 .
[35] A. Rimm,et al. The association of body weight with recurrent cancer of the breast , 1978, Cancer.
[36] H. Takei,et al. Oral high-dose medroxyprogesterone acetate treatment for recurrent breast cancer. , 1995, Anticancer research.
[37] E. Wynder,et al. Epidemiology and natural history of breast cancer. Implications for the body weight-breast cancer controversy. , 1990, The Surgical clinics of North America.
[38] L. Kuller. Eating fat or being fat and risk of cardiovascular disease and cancer among women. , 1994, Annals of epidemiology.
[39] L. Sachs,et al. Nutritional concerns of women with breast cancer. , 1993, Journal of cancer education : the official journal of the American Association for Cancer Education.
[40] J. K. Martin,et al. Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausal women with node-positive breast cancer. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] M. Knobf. Symptoms and rehabilitation needs of patients with early stage breast cancer during primary therapy , 1990, Cancer.
[42] R. Verreault,et al. Body weight and prognostic indicators in breast cancer. Modifying effect of estrogen receptors. , 1989, American journal of epidemiology.
[43] C. Spurr,et al. High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] G. Colditz. Fat, estrogens, and the time frame for prevention of breast cancer. , 1995, Epidemiology.
[45] R. Jeffery,et al. Diet intervention methods to reduce fat intake: nutrient and food group composition of self-selected low-fat diets. , 1990, Journal of the American Dietetic Association.
[46] E. Wynder,et al. Clinical trials of dietary interventions to enhance cancer survival. , 1990, Progress in clinical and biological research.
[47] M. Huntington,et al. Weight gain in patients receiving adjuvant chemotherapy for carcinoma of the breast , 1985, Cancer.
[48] G. Lyman,et al. Obesity, body fat distribution, and sex hormones in breast cancer patients , 1991, Cancer.
[49] L. Holm,et al. Dietary intervention in breast cancer patients: effects on food choice. , 1992, European journal of clinical nutrition.
[50] W. D. Selles,et al. Changes in food patterns during a low-fat dietary intervention in women. , 1990, Journal of the American Dietetic Association.
[51] Stephen E. Jones,et al. Adjuvant Therapy of Cancer , 1990 .
[52] G. Evans,et al. Weight changes in women with metastatic breast cancer treated with megestrol acetate: a comparison of standard versus high-dose therapy. , 1990, Seminars in oncology.
[53] J. Carpenter,et al. Weight gain with breast cancer adjuvant treatment , 1991, Cancer.
[54] R. Klein,et al. Association of dietary and life-style factors with sex hormones in postmenopausal women. , 1995, Epidemiology.
[55] H. Bingham. Obesity and breast disease , 1990 .
[56] M. Kimura,et al. Biological characteristics of breast cancer in obesity. , 1976, The Tohoku journal of experimental medicine.
[57] R. Jeffery,et al. Is obesity due to overeating and inactivity, or to a defective metabolic rate? A review , 1991 .
[58] C. Grindel,et al. Food intake of women with breast cancer during their first six month of chemotherapy. , 1989, Oncology nursing forum.
[59] P. Wingo,et al. Cancer statistics, 1995 , 1995, CA: a cancer journal for clinicians.
[60] R. Prentice,et al. Dietary fat reduction and plasma estradiol concentration in healthy postmenopausal women. The Women's Health Trial Study Group. , 1990, Journal of the National Cancer Institute.
[61] L. Ottestad,et al. The effect of pre-morbid height and weight on the survival of breast cancer patients. , 1990, British Journal of Cancer.
[62] C. Enriori,et al. Decrease of circulating level of SHBG in postmenopausal obese women as a risk factor in breast cancer: reversible effect of weight loss. , 1986, Gynecologic oncology.
[63] D. Ingram,et al. Obesity and breast disease. The role of the female sex hormones , 1989, Cancer.
[64] E. Wynder,et al. Breast cancer--the optimal diet. , 1992, Advances in experimental medicine and biology.
[65] J. Poortman,et al. Relationship of weight to the promotion of breast cancer after menopause. , 1981, Nutrition and cancer.
[66] Foltz At. Weight gain among stage II breast cancer patients: a study of five factors. , 1985 .